These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26376174)
21. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukemia do not necessarily mark preleukemic cells. Raynaud SD; Brunet B; Chischportich M; Bayle J; Gratecos N; Pesce A; Dujardin P; Flandrin G; Ayraud N Leukemia; 1994 Feb; 8(2):245-9. PubMed ID: 8309249 [TBL] [Abstract][Full Text] [Related]
22. [Combined application of multiplex reverse transcription-polymerase chain reaction and karyotype analysis to detection of clonal chromosomal aberrations in acute myeloid leukemia]. Huang L; Li CR; Zhang H; Sun LS; Liu WL; Zhou JF Ai Zheng; 2007 Sep; 26(9):1029-33. PubMed ID: 17927867 [TBL] [Abstract][Full Text] [Related]
23. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings. Cui W; Zhang D; Cunningham MT; Tilzer L Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197 [TBL] [Abstract][Full Text] [Related]
35. Analysis of hematogones in bone marrow from acute myeloid leukaemia cases posttherapy. Zheng J; Du W; Yao J; You Y; Li W; He Y; Li X; Liu W; Wu Y; Hu Y; Jin R; Zou P; Huang S; Hu Y; Zhang M Eur J Clin Invest; 2013 Nov; 43(11):1140-6. PubMed ID: 23992300 [TBL] [Abstract][Full Text] [Related]
36. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide. Perot C; van den Akker J; Laporte JP; Douay L; Lopez M; Stachowiak J; Isnard F; Taillemite JL; Najman A; Gorin NC Leukemia; 1993 Apr; 7(4):509-15. PubMed ID: 8464228 [TBL] [Abstract][Full Text] [Related]
37. Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin. Ottone T; Zaza S; Divona M; Hasan SK; Lavorgna S; Laterza S; Cicconi L; Panetta P; Di Giandomenico J; Cittadini M; Ciardi C; Montefusco E; Franchi A; Annino L; Venditti A; Amadori S; Lo-Coco F Br J Haematol; 2013 May; 161(4):533-40. PubMed ID: 23480665 [TBL] [Abstract][Full Text] [Related]
38. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902 [TBL] [Abstract][Full Text] [Related]
39. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia. Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724 [TBL] [Abstract][Full Text] [Related]
40. A cytogenetic model predicts relapse risk and survival in patients with acute myeloid leukemia undergoing hematopoietic stem cell transplantation in morphologic complete remission. Rashidi A; Cashen AF Leuk Res; 2015 Jan; 39(1):77-81. PubMed ID: 25481050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]